Highly purified human immunodeficiency virus type 1 reveals a virtual absence of vif in virions

被引:188
作者
Dettenhofer, M [1 ]
Yu, XF [1 ]
机构
[1] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
关键词
D O I
10.1128/JVI.73.2.1460-1467.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The vif gene of human immunodeficiency virus type 1 (HIV-1) is essential for the productive infection of primary blood-derived lymphocytes, macrophages, and certain human T-cell lines. It has been shown that Vif is associated with HIV-1 virions purified by sucrose density-equilibrium gradient analysis. However, the specificity of Vif incorporation into virions has not been determined. Moreover, recent studies have demonstrated that standard HIV-1 particle preparations created with sucrose density-equilibrium gradients are contaminated with cell-derived microvesicles. Here we demonstrate, as previously reported, that Vif cosediments with HIV-1 particles in sucrose density-equilibrium gradient analysis. However, we also found that, when Vif was expressed in the absence of all other HIV-1-encoded gene products and then isolated by sucrose density-equilibrium gradient centrifugation from extracellular supernatants, its sedimentation pattern was largely unaltered, suggesting that Vif can be secreted from cells. Using a newly developed OptiPrep velocity gradient method, we were able to physically separate most of the extracellular Vif from the HIV-1 virions without disrupting the infectivity of the virus. By titrating serial dilutions of purified Vif and Gag against the viral peak fraction in the OptiPrep gradient, we demonstrate that <1.0 Vif molecule per virion was present. This study shows that Vif is not significantly present in HIV-1 virions, a finding which is consistent with the idea that Vif functions predominantly in the virus-producing cells during virus assembly, The OptiPrep velocity gradient technique described here could be an easy and rapid way to purify HIV and other enveloped viruses from microvesicles and/or cell debris.
引用
收藏
页码:1460 / 1467
页数:8
相关论文
共 65 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[3]  
[Anonymous], 1996, FIELDS VIROLOGY
[4]   CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES [J].
ARTHUR, LO ;
BESS, JW ;
SOWDER, RC ;
BENVENISTE, RE ;
MANN, DL ;
CHERMANN, JC ;
HENDERSON, LE .
SCIENCE, 1992, 258 (5090) :1935-1938
[5]   Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis [J].
Berthoux, L ;
Pechoux, C ;
Ottmann, M ;
Morel, G ;
Darlix, JL .
JOURNAL OF VIROLOGY, 1997, 71 (09) :6973-6981
[6]   Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations [J].
Bess, JW ;
Gorelick, RJ ;
Bosche, WJ ;
Henderson, LE ;
Arthur, LO .
VIROLOGY, 1997, 230 (01) :134-144
[7]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY [J].
BORMAN, AM ;
QUILLENT, C ;
CHARNEAU, P ;
DAUGUET, C ;
CLAVEL, F .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2058-2067
[8]   Phenotypically Vif(-) human immunodeficiency virus type 1 is produced by chronically infected restrictive cells [J].
Bouyac, M ;
Rey, F ;
Nascimbeni, M ;
Courcoul, M ;
Sire, J ;
Blanc, D ;
Clavel, F ;
Vigne, R ;
Spire, B .
JOURNAL OF VIROLOGY, 1997, 71 (03) :2473-2477
[9]   Human immunodeficiency virus type 1 Vif protein binds to the Pr55(Gag) precursor [J].
Bouyac, M ;
Courcoul, M ;
Bertola, G ;
Baudat, Y ;
Gabuzda, D ;
Blanc, D ;
Chazal, N ;
Boulanger, P ;
Sire, J ;
Vigne, R ;
Spire, B .
JOURNAL OF VIROLOGY, 1997, 71 (12) :9358-9365
[10]   Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription [J].
Braaten, D ;
Franke, EK ;
Luban, J .
JOURNAL OF VIROLOGY, 1996, 70 (06) :3551-3560